Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout

Abstract

In this hypothesis-generating study, gout patients who took colchicine had a significantly lower prevalence of MI and exhibited trends toward reduced all-cause mortality and lower CRP level versus those who did not take colchicine.